Home ›
NPI 1700120318
NPI deactivated
1700120318
1700120318 was paid $414K by Medicaid between Jan 2018 and Jan 2021, across 67 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 29% of everything it billed.
33Billing provider info1700120318
33aNPI1700120318
33bProvider type—
28Total paid$414K
24GClaims35,632
24DCodes billed67
24AFirst – last monthJan 2018 – Jan 2021
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,795 | $69K | |
| 2019 | 10,412 | $95K | |
| 2020 | 12,009 | $249K | |
| 2021 | 416 | $918.09 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 29% | 1,492 | 1,416 | $119K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21% | 1,191 | 940 | $88K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5.5% | 1,495 | 1,418 | $23K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.9% | 1,176 | 930 | $20K |
| 87581 | 4.7% | 1,498 | 1,422 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 435 | 435 | $17K |
| 87486 | 3.1% | 1,497 | 1,421 | $13K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 2.6% | 161 | 159 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 2,130 | 2,052 | $10K |
| 80074 | 2.2% | 430 | 427 | $9K | |
| 86001 | 1.5% | 137 | 132 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.3% | 1,117 | 1,082 | $6K |
55 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 1,666 | $5K |
| 86003 | 1.2% | 149 | $5K | |
| 80061 | Lipid panel | 1.2% | 1,740 | $5K |
| 80053 | Comprehensive metabolic panel | 1.2% | 1,956 | $5K |
| 86038 | <1% | 440 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,551 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 223 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 223 | $3K |
| 82607 | <1% | 1,013 | $3K | |
| 84481 | <1% | 495 | $3K | |
| 83935 | <1% | 411 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 167 | $2K |
| 84439 | <1% | 535 | $2K | |
| 99000 | <1% | 940 | $2K | |
| 82746 | <1% | 680 | $2K | |
| 82728 | <1% | 637 | $2K | |
| 84153 | <1% | 555 | $2K | |
| 86677 | <1% | 431 | $2K | |
| 83540 | <1% | 624 | $2K | |
| 81002 | <1% | 1,259 | $1K | |
| 86592 | <1% | 405 | $1K | |
| 86701 | <1% | 157 | $1K | |
| 84550 | <1% | 756 | $1K | |
| 86063 | <1% | 417 | $1K | |
| 84466 | <1% | 297 | $958.04 | |
| 82043 | <1% | 531 | $755.07 | |
| 85651 | <1% | 457 | $716.70 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 302 | $697.20 |
| 86430 | <1% | 429 | $616.24 | |
| 84480 | <1% | 374 | $584.47 | |
| 86140 | <1% | 452 | $570.10 | |
| 0100U | <1% | 14 | $500.00 | |
| 84436 | <1% | 349 | $455.90 | |
| 83550 | <1% | 188 | $354.64 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,046 | $342.53 |
| 82670 | <1% | 111 | $245.85 | |
| 80164 | <1% | 61 | $215.71 | |
| 84479 | <1% | 240 | $205.14 | |
| 84144 | <1% | 71 | $90.60 | |
| 84402 | <1% | 14 | $68.04 | |
| 83001 | <1% | 71 | $65.00 | |
| 83002 | <1% | 71 | $64.88 | |
| 80076 | <1% | 74 | $31.66 | |
| 84146 | <1% | 58 | $17.11 | |
| 83735 | <1% | 13 | $5.42 | |
| 87507 | 0% | 26 | $0.00 | |
| 86704 | 0% | 25 | $0.00 | |
| 81226 | 0% | 36 | $0.00 | |
| 87340 | 0% | 14 | $0.00 | |
| 86706 | 0% | 13 | $0.00 | |
| 81015 | 0% | 28 | $0.00 | |
| 81225 | 0% | 36 | $0.00 | |
| 86803 | 0% | 16 | $0.00 | |
| 86708 | 0% | 13 | $0.00 | |
| 83970 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.